FDA Guidances in 2020: A high-level pharma, device and diagnostic overview 17 February 2021
2020 was a year like no other and COVID-19 has certainly challenged the Pharmaceutical, Medical Device and Diagnostic Industries. Even with all that was going on with COVID-19 and making COVID-19-related medical products available, 2020 was a banner year for guidances issued by the US Food and Drug Administration (FDA). In this month’s webinar, our Directors, Rob Stringer and Terrance Thiel will discuss those guidances that have the most impact on the pharma, medical device and diagnostic products, by providing an overview, understanding and examples of these guidances’ effects, including the potential effects to other regulatory jurisdictions. Please join us for this February webinar and feel free to ask any FDA guidance questions in advance.
Presenters: Robert Stringer and TJ Thiel, Brandwood CKC